Resume Methotrexate After Infection Resolution
You should restart methotrexate 25 mg weekly now that the acute infection has resolved, provided the lingering cough is not accompanied by dyspnea, fever, or constitutional symptoms. 1
Clinical Assessment Required Before Restarting
Before resuming methotrexate, evaluate for signs of methotrexate-induced pneumonitis versus simple post-viral cough:
Red flags that would contraindicate restarting:
- Progressive dyspnea (not just cough alone)
- Fever or constitutional symptoms (fatigue, malaise, weight loss)
- Hypoxemia or decreased oxygen saturation
- New interstitial infiltrates on chest imaging
- Impaired pulmonary function testing 2, 3
If only lingering cough is present without the above features:
- This likely represents post-viral airway irritation, not methotrexate pneumonitis
- Isolated cough without dyspnea, constitutional symptoms, or radiographic changes does not require withholding methotrexate 2
Rationale for Resumption
The multinational evidence-based guidelines do not mandate prolonged methotrexate discontinuation for routine upper respiratory infections 1. While the perioperative recommendation (Recommendation 9) states methotrexate can be safely continued through elective surgery 1, the extrapolation is that brief interruptions for minor illnesses should be followed by prompt resumption once infection resolves.
Key considerations:
- Three missed doses (3 weeks) represents significant time off an anchor DMARD
- Risk of disease flare increases with prolonged methotrexate interruption
- The cold has resolved (only lingering cough remains)
- No evidence supports extended holds for uncomplicated viral infections
Monitoring After Restart
Once methotrexate is resumed:
- Check CBC, creatinine, and liver enzymes within 1-2 weeks of restarting, as the patient has been off therapy 1
- Ensure folic acid supplementation (at least 5 mg weekly) is continued 1, 4
- Monitor clinically for any respiratory symptom progression over the next 2-4 weeks
When NOT to Restart
Do not restart methotrexate if:
- New or worsening dyspnea develops
- Chest X-ray shows new interstitial infiltrates
- Oxygen saturation is decreased
- Constitutional symptoms (fever, significant fatigue) persist
- Pulmonary function tests show restriction or decreased diffusion capacity 2, 3
In these scenarios, methotrexate-induced pneumonitis must be excluded before any rechallenge. This would require pulmonary consultation, imaging, and potentially bronchoalveolar lavage 2, 5.
Common Pitfall
The most critical error is confusing isolated post-viral cough (benign, self-limited) with early methotrexate pneumonitis (progressive, potentially fatal). Methotrexate pneumonitis presents with the triad of dyspnea, constitutional symptoms, and radiographic infiltrates—not isolated cough alone 2, 6. Unnecessarily prolonging methotrexate discontinuation for simple post-infectious cough increases risk of RA flare without safety benefit.